logo

IBRX

ImmunityBioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

IBRX fundamentals

ImmunityBio (IBRX) released its earnings on Aug 5, 2025: revenue was 26.43M (YoY +2423.88%), beat estimates; EPS was -0.1 (YoY +50.00%), met estimates.
Revenue / YoY
26.43M
+2423.88%
EPS / YoY
-0.1
+50.00%
Report date
Aug 5, 2025
EPS
Revenue

Revenue & Expenses

IBRX has released its 2025 Q3 earnings report, with revenue of 32.06M, reflecting a YoY change of 425.07%, and net profit of -67.27M, showing a YoY change of 21.55%. The Sankey diagram below clearly presents IBRX's revenue sources and cost distribution.

Key Indicators

ImmunityBio (IBRX) key financial stats and ratios, covering profitability, financial health, and leverage.
ImmunityBio (IBRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ImmunityBio (IBRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ImmunityBio (IBRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ImmunityBio (IBRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ImmunityBio (IBRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield